Product: BENLYSTA  (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
Reason for recall: CGMP Deviations; potential temperature excursions due to transit delays
Recall initiated: 20250421
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated